search
Back to results

Open Versus Percutaneous Insertion of CAPD Catheters

Primary Purpose

Renal Failure

Status
Withdrawn
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Percutaneous Insertion catheter
Open insertion Catheter
Sponsored by
Hull University Teaching Hospitals NHS Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Renal Failure focused on measuring Dialysis, Peritoneal, Catheter, Surgery

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Potential participating patients will be identified by referral to the vascular surgery department for insertion of CAPD catheter for peritoneal access.

Specific inclusion criteria necessary for invitation to study participation;

  • Patients referred to vascular consultants for CAPD catheter insertion

General inclusion criteria:

  • Ability to give informed written consent

Specific exclusion criteria:

  • Previous abdominal surgery via midline incision
  • Unfit for general anaesthetic
  • Aged under 18 at time of referral

General exclusion criteria:

  • Inability to give informed written consent
  • Inability to attend follow up appointments

Withdrawal criteria:

  • Patient request
  • Patient non compliance with study protocol

Sites / Locations

  • Hull Royal Infirmary

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Percutaneous insertion

Open insertion

Arm Description

To undergo insertion of catheter using percutaneous technique under local anaesthetic

To undergo insertion of catheter using open technique under general anaesthetic

Outcomes

Primary Outcome Measures

Catheter survival
Time to catheter removal for any reason.recorded as percentage inn situ at 6, 12,18,etc months post procedure.

Secondary Outcome Measures

Peri operative complications (bleeding, bowel injury)
All complications occuring at time of procedure and in 24 hours immediately post procedure.
Mechanical Complication (drainage failure, displacement, fluid leak)
All mechanical complications recorded during follow up period. Note of timing of complications will be made in results. Early = within 30 days, late = beyond 30 days
Infective complications (exit site, tunnel, peritonitis)
All infective complications recorded during follow up period. Note of timing of complications will be made in results. Early = within 30 days, late = beyond 30 days
Operative time
Time to complete procedure from start to finish.
Technical Success of placement
Assessment of whether a working and useable catheter is in situ at the end of the procedure.
Length of admission
Length of admission post procedure according to strict discharge criteria.
Patient reported pain post procedure
Analgesia and daily pain scoring diaries will be issued to patients post procedure. These will record patient reported pain at 24 hour intervals to 5 days as well as analgesia taken during the same period.
Quality of life assessment by questionnaire
Estimated cost of care episode
Overall estimated cost of admission, procedure, ongoing care of catheter and management of complications arising from catheter or procedure will be calculated.

Full Information

First Posted
December 1, 2009
Last Updated
July 18, 2019
Sponsor
Hull University Teaching Hospitals NHS Trust
Collaborators
University of Hull
search

1. Study Identification

Unique Protocol Identification Number
NCT01023191
Brief Title
Open Versus Percutaneous Insertion of CAPD Catheters
Official Title
A Prospective Randomized Controlled Trial of Local Anaesthetic Percutaneous Insertion Versus General Anaesthetic Open Surgical Placement of Continuous Peritoneal Dialysis Catheters in a University Teaching Hospital
Study Type
Interventional

2. Study Status

Record Verification Date
July 2019
Overall Recruitment Status
Withdrawn
Why Stopped
Did not pass set-up phase
Study Start Date
February 2015 (undefined)
Primary Completion Date
July 2018 (Anticipated)
Study Completion Date
September 2018 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hull University Teaching Hospitals NHS Trust
Collaborators
University of Hull

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Healthy kidneys clean your blood by removing excess fluid, minerals, and wastes. When your kidneys fail, harmful wastes build up in your body and your body may retain excess fluid. When this happens, you need treatment to replace the work of your failed kidneys. This may be with a dialysis machine using haemodialysis or with fluid in the abdomen or peritoneal dialysis. In peritoneal dialysis, a tube called a catheter is put in the abdomen wall and used to fill your abdomen with a cleansing liquid called dialysis solution. The walls of your abdominal cavity are lined with a membrane called the peritoneum, which allows waste products and extra fluid to pass from your blood into the dialysis solution. These wastes and fluid are removed from the body when the dialysis fluid is drained and replaced with a fresh solution. The tubes or catheters used to exchange the fluid are currently positioned using a general anaesthetic (with the patient awake) and an operation with a cut under the belly button. Newer techniques using local anaesthetic (with the patient awake and the area numbed) and requiring only a small cut in the skin have been used. No one has ever directly compared the two techniques. The investigators aim is to perform a direct comparison between the two techniques to look at the complications and time required for surgery and length of hospital stay required. The investigators will also look at the patients satisfaction and pain scores with each technique to help gather evidence as to which is likely to be the best technique to use from now on.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Failure
Keywords
Dialysis, Peritoneal, Catheter, Surgery

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Percutaneous insertion
Arm Type
Active Comparator
Arm Description
To undergo insertion of catheter using percutaneous technique under local anaesthetic
Arm Title
Open insertion
Arm Type
Active Comparator
Arm Description
To undergo insertion of catheter using open technique under general anaesthetic
Intervention Type
Procedure
Intervention Name(s)
Percutaneous Insertion catheter
Intervention Description
Insertion of CAPD catheter using percutaneous seldinger technique under local anaesthetic +/- sedation as required
Intervention Type
Procedure
Intervention Name(s)
Open insertion Catheter
Intervention Description
Present technique of open insertion under general anaesthetic. Incision to lower abdomen and direct visualisation of catheter tip placement into pelvis.
Primary Outcome Measure Information:
Title
Catheter survival
Description
Time to catheter removal for any reason.recorded as percentage inn situ at 6, 12,18,etc months post procedure.
Time Frame
Ongoing (recorded at 6 month intervals)
Secondary Outcome Measure Information:
Title
Peri operative complications (bleeding, bowel injury)
Description
All complications occuring at time of procedure and in 24 hours immediately post procedure.
Time Frame
24 hrs post procedure
Title
Mechanical Complication (drainage failure, displacement, fluid leak)
Description
All mechanical complications recorded during follow up period. Note of timing of complications will be made in results. Early = within 30 days, late = beyond 30 days
Time Frame
ongoing (reported at 30 days and monthly thereafter)
Title
Infective complications (exit site, tunnel, peritonitis)
Description
All infective complications recorded during follow up period. Note of timing of complications will be made in results. Early = within 30 days, late = beyond 30 days
Time Frame
ongoing (reported at 30 days and monthly thereafter)
Title
Operative time
Description
Time to complete procedure from start to finish.
Time Frame
Average of 2 hours post procedure
Title
Technical Success of placement
Description
Assessment of whether a working and useable catheter is in situ at the end of the procedure.
Time Frame
Average of 2 hours post procedure
Title
Length of admission
Description
Length of admission post procedure according to strict discharge criteria.
Time Frame
Average of 48 hours post procedure
Title
Patient reported pain post procedure
Description
Analgesia and daily pain scoring diaries will be issued to patients post procedure. These will record patient reported pain at 24 hour intervals to 5 days as well as analgesia taken during the same period.
Time Frame
24 hour intervals to 5 days post procedure
Title
Quality of life assessment by questionnaire
Time Frame
Within 24 hours prior to procedure, and again at both 5 days and 3 months post procedure
Title
Estimated cost of care episode
Description
Overall estimated cost of admission, procedure, ongoing care of catheter and management of complications arising from catheter or procedure will be calculated.
Time Frame
3 months post procedure

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Potential participating patients will be identified by referral to the vascular surgery department for insertion of CAPD catheter for peritoneal access. Specific inclusion criteria necessary for invitation to study participation; Patients referred to vascular consultants for CAPD catheter insertion General inclusion criteria: Ability to give informed written consent Specific exclusion criteria: Previous abdominal surgery via midline incision Unfit for general anaesthetic Aged under 18 at time of referral General exclusion criteria: Inability to give informed written consent Inability to attend follow up appointments Withdrawal criteria: Patient request Patient non compliance with study protocol
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ian C Chetter, MB ChB
Organizational Affiliation
University of Hull
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hull Royal Infirmary
City
Hull
State/Province
East Yorkshire
ZIP/Postal Code
HU3 2JZ
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Open Versus Percutaneous Insertion of CAPD Catheters

We'll reach out to this number within 24 hrs